Stock Price Forecast

Dec. 22, 2022


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Abiomed Inc. chart...

About the Company

Abiomed Europe GmbH, Aachen / Germany, as affiliate of Abiomed Inc. headquartered in Danvers, Massachusetts, USA, is a leading medical technology company in the field of circulatory support. Its products aim to enable heart recovery by improving blood circulation and/or heart pump function.

CEO

Michael Minogue

Exchange

NASDAQ

Website

www.abiomed.com

$174M

Total Revenue

2K

Employees

$17B

Market Capitalization

71.38

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $ABMD News

FDA issues alert on Abiomed heart pump associated with 49 deaths

23d ago, source: The Business Journals

The Danvers-based company was one of the largest medical device firms in Massachusetts before it was bought by Johnson & Johnson Inc. (NYSE: JNJ) for $16.6 billion in December 2022. Abiomed became ...

New warnings about heart pumps linked to more than 100 serious injuries, including 49 deaths

24d ago, source: 6abc News

The pumps, left-sided Impella heart pumps made by Johnson & Johnson MedTech's Abiomed, have been linked to more than 100 serious injuries, including 49 deaths. The alert advises customers of new ...

Abiomed Heart Pumps Linked to 49 Deaths

24d ago, source: U.S. News & World Report

These left-sided Impella heart pumps are made by Abiomed, a subsidiary of Johnson & Johnson MedTech. Abiomed posted the new warning on the devices on the U.S. Food and Drug Administration's website.

New warnings about heart pumps linked to 49 deaths

27d ago, source: CNN

The pumps, left-sided Impella heart pumps made by Johnson & Johnson MedTech’s Abiomed, have been linked to more than 100 serious injuries, including 49 deaths. The alert advises customers of new ...

Johnson & Johnson Strong Strategic Fit For Shockwave Medical, But Medtronic, Boston Scientific Could Be Other Bidder, Says Analyst

29d ago, source: Benzinga.com

Shockwave Medical is a cardiovascular medical device. In 2022, Johnson & Johnson acquired heart failure device-focused Abiomed Inc. for an upfront payment of $380.00 per share in cash ...

Johnson & Johnson To Buy Shockwave In $13.1 Bln Deal

20d ago, source:

(RTTNews) - Drug major Johnson & Johnson (JNJ) announced Friday its agreement to acquire Shockwave Medical, Inc. (SWAV) for ...

Johnson & Johnson Strong Strategic Fit For Shockwave Medical, But Medtronic, Boston Scientific Could Be Other Bidder, Says Analyst

on MSN ago, source:

Tuesday, Shockwave Medical Inc (NASDAQ:SWAV) shares traded higher following a Wall Street Journal report suggesting Johnson & ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...